Hologic Inc (HOLX)-Medical Equipment-Deals and Alliances Profile

Hologic Inc (HOLX)-Medical Equipment-Deals and Alliances Profile


  • Products Id :- GDME713D
  • |
  • Pages: 61
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Hologic Inc (Hologic) is a medical device company. It develops, manufactures and supplies diagnostic products, medical imaging systems and surgical products. The company offers diagnostic products to aid in the diagnosis of human diseases and screen donated human blood; a broad portfolio of breast imaging and related products and accessories; gynecology surgical products including endometrial ablation system and hysteroscopic tissue removal system; and skeletal health products including dual-energy X-ray bone densitometry systems and mini C-arm imaging products. The company offers these solutions to surgeons, hospitals, clinical laboratories and healthcare providers. Hologic offers its products and services through a network of direct sales and service forces and through independent distributors and sales representatives. The company operates in the Americas, Europe and Asia-Pacific. Hologic is headquartered in Marlborough, Massachusetts, the US.

Hologic Inc (HOLX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Hologic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Hologic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Hologic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Hologic Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9

Hologic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Hologic Inc, Medical Equipment, Deal Details 12

Asset Purchase 12

Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 12

Private Equity 13

Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 13

Partnerships 14

MeVis Medical Enters into Licensing Agreement with Hologic 14

Microsulis Medical Enters Into Licensing Agreement With Hologic 14

Seegene Enters into Agreement with Hologic 15

U.S. Department of Health and Human Services Enters into Agreement with Hologic 16

Bovie Medical Enters into Agreement with Hologic 17

Metamark Genetics Enters into Distribution Agreement with Hologic 18

Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 18

Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 19

Quest Diagnostics Enters Into Co-Development Agreement With Hologic 20

Debt Offering 21

Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 21

Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion 22

Asset Transactions 22

Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 22

Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 24

Atossa Genetics Acquires Rights to Microcatheter System from Hologic 25

Acquisition 26

Hologic Acquires Cynosure in Tender Offer 26

Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 28

Hologic Acquires Beijing Healthcome For Up To US$17 Million 30

Hologic Acquires TCT International 30

Hologic Acquires Interlace Medical 31

Hologic Inc-Key Competitors 34

Key Employees 35

Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Recent Developments 39

Financial Announcements 39

May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 39

Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 41

Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 43

Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016 45

Apr 27, 2016: Hologic Announces Financial Results for Second Quarter of Fiscal 2016 47

Jan 27, 2016: Hologic Announces Financial Results for First Quarter of Fiscal 2016 48

Corporate Communications 50

May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 50

Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 51

Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors 52

Mar 02, 2016: Chris Coughlin Elected to Hologic Board of Directors 53

Legal and Regulatory 54

Jan 19, 2016: Hologic's Tepnel Pharma Services Achieves ISO 17025 Accreditation for Extraction and Genotyping Services 54

Product News 55

Jun 29, 2017: Hologic's New Panther Fusion System, Flu and Respiratory Assays Now CE Marked in Europe 55

Mar 01, 2017: Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 56

Nov 25, 2016: Hologic to Showcase Award-Winning Breast Screening and Interventional Solutions at RSNA 2016 57

Jan 06, 2016: Metamark Genetics to Serve as Exclusive Sales Agent for Hologic's Proprietary Prostate Cancer Test 58

Other Significant Developments 59

Aug 09, 2016: HHS awards $4.1 Million to Hologic to Develop better Zika Blood Screening Test 59

Jul 21, 2016: Bovie Medical Announces Sales Channel Partnership Agreement with Hologic for J-Plasma 60

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61

List of Figures

Hologic Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Hologic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Hologic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Hologic Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Hologic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Hologic Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 7

Hologic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Hologic Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 9

List of Tables

Hologic Inc, Medical Equipment, Key Facts, 2016 1

Hologic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Hologic Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6

Hologic Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7

Hologic Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8

Hologic Inc, Deals By Market, 2011 to YTD 2017 9

Hologic Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10

Hologic Acquires PCA3 Assets from DiagnoCure for USD4.7 Million 12

Percipient Capital Completes Management Buyout Of Elucigene Diagnostics 13

MeVis Medical Enters into Licensing Agreement with Hologic 14

Microsulis Medical Enters Into Licensing Agreement With Hologic 14

Seegene Enters into Agreement with Hologic 15

U.S. Department of Health and Human Services Enters into Agreement with Hologic 16

Bovie Medical Enters into Agreement with Hologic 17

Metamark Genetics Enters into Distribution Agreement with Hologic 18

Metamark Genetics Plans to Enter into Co-Development Agreement with Hologic 18

Medimaps Enters into Distribution Agreement with Hologic for TBS iNsight 19

Quest Diagnostics Enters Into Co-Development Agreement With Hologic 20

Hologic Raises USD1 Billion in Private Placement of 5.25% Notes Due 2022 21

Hologic Completes Private Placement Of Senior Notes Due 2020 For US$1 Billion 22

Grifols Acquires Nucleic Acid Testing Donor Screening Unit from Hologic for USD1.85 Billion 22

Immucor Completes Acquisition Of Lifecodes Business Of Hologic For US$95 Million 24

Atossa Genetics Acquires Rights to Microcatheter System from Hologic 25

Hologic Acquires Cynosure in Tender Offer 26

Hologic Completes Acquisition Of Gen-Probe For US$3.7 Billion 28

Hologic Acquires Beijing Healthcome For Up To US$17 Million 30

Hologic Acquires TCT International 30

Hologic Acquires Interlace Medical 31

Hologic Inc, Key Competitors 34

Hologic Inc, Key Employees 35

Hologic Inc, Other Locations 36

Hologic Inc, Subsidiaries 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Hologic Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16608
Site License
USD 500 INR 33215
Corporate User License
USD 750 INR 49823

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com